Pmv Pharmaceuticals Inc (PMVP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 208,783 | 361,422 | 0 | 0 | 0 |
| Marketable Securities | 122,706 | N/A | 0 | 0 | 0 |
| TOTAL | $334,953 | $364,761 | $0 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 697 | 569 | N/A | N/A | N/A |
| Investments And Advances | 16,891 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 1,852 | 201 | 0 | 0 | 0 |
| TOTAL | $19,440 | $770 | $N/A | $N/A | $N/A |
| Total Assets | $354,393 | $365,531 | $0 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,252 | 1,607 | 0 | 0 | 0 |
| Accrued Expenses | 3,878 | 4,803 | 0 | 0 | 0 |
| TOTAL | $5,796 | $6,410 | $0 | $0 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 302 | 0 | 0 | 0 | 0 |
| TOTAL | $302 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $6,098 | $6,410 | $0 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 45,033 | 44,783 | 44,774 | N/A | N/A |
| Retained earnings | -121,482 | -109,880 | 0 | 0 | 0 |
| Other shareholders' equity | -13 | 0 | 0 | 0 | 0 |
| TOTAL | $348,295 | $359,121 | $0 | $0 | $0 |
| Total Liabilities And Equity | $354,393 | $365,531 | $0 | $0 | $0 |